Miller v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided December 7, 2020·No. 16-946·Unpublished

Opinion

CORRECTED

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 16-0946V Filed: May 31, 2019 UNPUBLISHED

**************************** The Estate of ARNOLD LEE MILLER, * Decedent, by and through * ARMICKA S. MILLER, as Personal * Representative, * * Order; Motion for Redaction; Untimely Petitioner, * Motion; Special Processing Unit (SPU); v. * Influenza (Flu) Vaccine; Guillain-Barre * Syndrome (GBS) SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * ****************************

ORDER DENYING REDACTION – SPECIAL PROCESSING UNIT 1

Dorsey, Chief Special Master:

On August 5, 2016, petitioner filed a petition as personal representative for the estate of her father, Arnold Lee Miller, for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the “Vaccine Act”). Approximately one year later, the undersigned determined petitioner was entitled to compensation for Mr. Miller’s Guillain-Barré Syndrome and subsequent death and awarded her compensation in the amount of $350,000.00 as the executrix of Mr. Miller’s estate. Ruling on Entitlement (“Ruling”), issued July 28, 2017 (ECF No. 28); Decision Awarding Damages (“Decision”), issued Aug. 3, 2017 (ECF No. 31). Both Ruling and Decision included a footnote indicating they would be posted to the court’s website and

1 Because this unpublished Order contains a reasoned explanation for the action in this case, the undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). To the extent petitioner would seek further redaction, in accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). allowing petitioner “14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy.” Ruling at 1 n.1; Decision at 1 n.1; see Vaccine Rule 18(b) (indicating decisions will be held for 14 days to allow the parties to file a request for redaction).

Over one year later, on August 22, 2018, petitioner filed an out of time motion requesting “redaction of her name from the Decision posted on the Court’s website.” Petitioner’s Motion for Discretionary Redaction (“Motion”) at 3 (ECF No. 43). Respondent filed his response on September 19, 2018. Respondent’s Response to Petitioner’s Motion for Redaction (“Response”) (ECF No. 45). For the reasons described below, the undersigned denies petitioner’s untimely filed motion for redaction.

I. Legal Standard

Section 12(d)(4)3 of the Vaccine Act, which is incorporated into Vaccine Rule 18, governs the disclosure of information submitted during a vaccine proceeding. Under § 12(d)(4)(A), information submitted in a vaccine proceeding may not be disclosed without the written consent of the party who submitted the information. Thus, Congress protected any information submitted by a party from public view, effectively sealing pre- decisional Vaccine Act proceedings. However, in 1989, Congress added § 12(d)(4)(B)4

3 Section 12(d)(4) provides:

(A) Except as provided in subparagraph (B), information submitted to a special master or the court in a proceeding on a petition may not be disclosed to a person who is not a party to the proceeding without the express written consent of the person who submitted the information.

(B) A decision of a special master or the court in a proceeding shall be disclosed, except that if the decision is to include information--

(i) which is trade secret or commercial or financial information which is privileged and confidential, or

(ii) which are medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of privacy,

and if the person who submitted such information objects to the inclusion of such information in the decision, the decision shall be disclosed without such information. 4 P.L. No. 101-239, 103 Stat. 2106. The legislative history for these changes is silent as to the reasons for adding the requirement that decisions of special masters be disclosed. The language prohibiting disclosure of information submitted during vaccine proceedings without written consent (which now appears at § 12(d)(4)(A)) was originally located at the end of the paragraph describing the special masters’ discovery powers (§ 12(c)(2) (Supp. V 1988)). In the 1989 amendments, this non-disclosure provision (which abrogated the common law rule that court filings are open to public scrutiny (see discussion in Section II.B.1. below)) was moved to § 12(d)(4)(A) and the new directive requiring the disclosure of vaccine decisions was added in § 12(d)(4)(B). See H.R. Conf. Rep. 101-386, at 512-13 (1989), reprinted in 1989 U.S.C.C.A.N. 3018, 3115-16; see also Castagna v. Sec’y of Health & Human Servs., No. 99-411V, 2011 WL 4348135, at *6-7 (Fed. Cl. Spec. Mstr. Aug. 25, 2011) (for a comprehensive discussion of the legislative history of the Vaccine Act and the 1989 amendments).

2 which requires the disclosure of vaccine decisions while allowing the parties to seek redaction of “trade secret or commercial or financial information which is privileged and confidential” (§ 12(d)(4)(B)(i)) or “medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of privacy” (§ 12(d)(4)(B)(ii)). Under the Vaccine Rules, the parties are given 14 days “to object to the public disclosure of any information furnished by that party.” Vaccine Rule 18(b).

Thirteen years after the addition of § 12(d)(4)(B), Congress enacted the E-Government Act of 20025 in an effort to improve public access to government information and services. Under § 205, which applies to all federal courts, Congress required the courts to establish and maintain websites where the public can view information including “all written opinions issued by the court” (published and unpublished). Because of privacy and security concerns associated with this increased public access, Congress instructed the Supreme Court to “prescribe rules” to address these concerns. E-Government Act § 205(c)(3). In response, the federal courts adopted Federal Rule of Civil Procedure (“FRCP”) 5.2. Approximately a year later, the United States Court of Federal Claims incorporated FRCP 5.2, minus subsection c (which deals with Social Security appeals and Immigration cases), into its Rules of the United States Court of Federal Claims (“RCFC”). RCFC 5.2 allows a party to use an abbreviated version of certain personal information when filing documents with the court. Under this rule, a party may redact a minor’s name to initials in any filed document. RCFC 5.2(a)(3).

Free access — add to your briefcase to read the full text and ask questions with AI

Miller v. Secretary of Health and Human Services, (uscfc 2020).

Miller v. Secretary of Health and Human Services (Miller v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related